The primary concern with limited scalability is that it restricts the number of patients who can benefit from cutting-edge treatments. Despite significant advancements in cancer research, many treatments remain confined to certain regions or patient groups, often leaving out those in low-income or rural areas. This disparity can lead to unequal treatment outcomes and exacerbate health inequities.
